MindWalk Screens 890,634 Antibody Sequences for Immune Risk in Under Five Hours
Financial Post ·
New white paper shows LensAI™ immunogenicity screening running at up to 43% lower cost per sequence on Amazon EC2 Hpc8a instances powered by AMD EPYC processors, making a critical drug-safety check practical at the scale AI-driven discovery now demands AUSTIN, Texas — MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today published a […]
Read More